Safety and Efficacy of a Drug Eluting Slim Modiolar Electrode Array

NAActive, not recruitingINTERVENTIONAL
Enrollment

56

Participants

Timeline

Start Date

January 3, 2025

Primary Completion Date

December 31, 2025

Study Completion Date

September 30, 2026

Conditions
Hearing Loss
Interventions
DEVICE

Cochlear implant

CI632D cochlear implant

DRUG

Dexamethasone

CI632D, dexamethasone-eluting cochlear implant

Trial Locations (11)

10010

New York Eye and Ear Infirmary, New York

10017

NYU Langone Health, New York

11042

Northwell Health Long Island Jewish Medical Center, New York

29425

Medical University of South Carolina, Charleston

44106

University Hospitals, Cleveland

48202

Henry Ford Health, Detroit

52242

University of Iowa, Iowa City

63141

Washington University, St Louis

80113

Rocky Mountain Ear Center, Englewood

90095

UCLA Medical Center, Los Angeles

97239

Oregon Health & Science University, Portland

Sponsors
All Listed Sponsors
collaborator

University of Iowa

OTHER

collaborator

LWB Consulting

UNKNOWN

collaborator

Althea Anagnostopoulos Harrington

UNKNOWN

collaborator

MV Clinical Research, LLC

UNKNOWN

lead

Cochlear

INDUSTRY

NCT06598059 - Safety and Efficacy of a Drug Eluting Slim Modiolar Electrode Array | Biotech Hunter | Biotech Hunter